logo

For the Inventor, By the Inventor

Monmouth Junction, NJ, United States of America

Ki-Bum Lee

USPTO Granted Patents = 11 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 25(Granted Patents)


Location History:

  • Monmouth Junction, NJ (US) (2014 - 2022)
  • Piscataway, NJ (US) (2024)

Company Filing History:

goldMedal11 out of 1,457 
 
Rutgers, the State University of New Jersey
 patents

Years Active: 2014-2025

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12350404 - 3D-porous hybrid anti-inflammatory nanoscaffold for drug delivery and tissue engineering (2025-07-08),
2. 12037529 - Luminescent layered composition and a method for using the composition (2024-07-16),
3. 11306326 - Biologically active synthetic nanoparticle constructs and methods of use thereof (2022-04-19),
4. 10100332 - Biologically active synthetic nanoparticle constructs and methods of use thereof (2018-10-16),
5. 9943606 - Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents (2018-04-17),
6. 9408918 - FRET-based mesoporous silica nanoparticles for real-time monitoring of drug release (2016-08-09),
7. 9234171 - Stem cell differentiation using novel light-responsive hydrogels (2016-01-12),
8. 9162885 - Graphene-encapsulated nanoparticle-based biosensor for the selective detection of biomarkers (2015-10-20),
9. 9114092 - Nanotopography-mediated reverse uptake platform for nucleic acid delivery and applications thereof (2015-08-25),
10. 9064965 - Zinc oxide-based thin film transistor biosensors with high sensitivity and selectivity (2015-06-23),
11. 8697667 - Cyclodextrin-modified polyamines for delivery of therapeutic molecules (2014-04-15),

Title: Ki-Bum Lee: Innovator in Nanotechnology and Drug Delivery

Introduction

Ki-Bum Lee is a prominent inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the fields of nanotechnology and drug delivery, holding a total of 11 patents. His innovative work focuses on developing advanced materials and methods that enhance therapeutic applications.

Latest Patents

Among his latest patents is the invention of a 3D-porous hybrid anti-inflammatory nanoscaffold for drug delivery and tissue engineering. This invention relates to biodegradable nanoscaffolds, specifically low dimension manganese oxide (MnO)-based nanoscaffolds that contain extracellular matrix (ECM) proteins and/or cationic polymers. The methods of use and manufacture of these nanoscaffolds are also detailed in the patent. Another notable patent is for a luminescent layered composition and a method for using this composition. This composition comprises at least three layers, with the first two layers containing either a sensitizer or an emitter, typically a metal ion or a dye. Upon exposure to light, such as infrared light, the composition produces visible and/or UV light, making it useful for various applications, including drug delivery and target detection.

Career Highlights

Ki-Bum Lee is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research and innovation in nanotechnology. His work has garnered attention for its potential impact on drug delivery systems and tissue engineering.

Collaborations

He collaborates with talented individuals such as Aniruddh Solanki and Sahishnu Patel, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ki-Bum Lee's contributions to nanotechnology and drug delivery exemplify the spirit of innovation in modern science. His patents reflect a commitment to improving therapeutic methods and advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…